Calcium sensitisers.
作者信息
Lee J A, Allen D G
机构信息
Department of Pathology, Royal Victoria Infirmary, Newcastle upon Tyne.
出版信息
BMJ. 1990 Mar 3;300(6724):551-2. doi: 10.1136/bmj.300.6724.551.
Abstract
摘要
相似文献
1
Calcium sensitisers.钙增敏剂
BMJ. 1990 Mar 3;300(6724):551-2. doi: 10.1136/bmj.300.6724.551.
2
[Calcium mobilizers and calcium sensitizers].[钙动员剂和钙敏化剂]
Nihon Rinsho. 2011 Nov;69 Suppl 9:417-22.
3
[Calcium sensitizers--a new group of drugs that increase myocardium contractility].[钙增敏剂——一类增强心肌收缩力的新型药物]
Duodecim. 2000;116(20):2181-3.
4
Advances in positive inotropic therapy: levosimendan.正性肌力治疗的进展：左西孟旦
Crit Care Med. 2003 Sep;31(9):2408-9. doi: 10.1097/01.CCM.0000084861.07091.F3.
5
[Contractile disorders of the heart and calcium].[心脏收缩功能障碍与钙]
Med Monatsschr Pharm. 1992 Oct;15(10):309-11.
6
Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?钙增敏作用是改善急性心力衰竭心肌收缩力的最佳策略吗？
Ital Heart J. 2003 May;4 Suppl 2:27S-33S.
7
The 1995 European Society of Cardiology.1995年欧洲心脏病学会
Circulation. 1995 Nov 1;92(9):2359-63. doi: 10.1161/01.cir.92.9.2359.
8
Levosimendan: perpetuum mobile?左西孟旦：永动机？
Eur Heart J. 2007 Feb;28(4):515. doi: 10.1093/eurheartj/ehl487. Epub 2007 Feb 5.
9
The vasoactive-inotropic score and levosimendan: time for LVIS?
J Cardiothorac Vasc Anesth. 2013 Apr;27(2):e15-6. doi: 10.1053/j.jvca.2012.11.009.
10
Patients with advanced heart failure and the effects of levosimendan.晚期心力衰竭患者及左西孟旦的作用
Am J Cardiol. 2007 Aug 15;100(4):742; author reply 742-3. doi: 10.1016/j.amjcard.2007.01.008. Epub 2007 Mar 26.
引用本文的文献
1
Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies.控制心脏张力机制的新观念：聚焦家族性扩张型心肌病（DCM）和针对肌节的治疗方法
Biomedicines. 2024 May 2;12(5):999. doi: 10.3390/biomedicines12050999.
2
Altering Calcium Sensitivity in Heart Failure: A Crossroads of Disease Etiology and Therapeutic Innovation.改变心力衰竭中的钙敏感性：疾病病因学和治疗创新的交叉点。
Int J Mol Sci. 2023 Dec 17;24(24):17577. doi: 10.3390/ijms242417577.
3
Discovery of Novel Small-Molecule Calcium Sensitizers for Cardiac Troponin C: A Combined Virtual and Experimental Screening Approach.新型小分子肌钙蛋白 C 钙敏剂的发现：一种结合虚拟和实验筛选方法。
J Chem Inf Model. 2020 Jul 27;60(7):3648-3661. doi: 10.1021/acs.jcim.0c00452. Epub 2020 Jul 7.
4
Levosimendan: a review of its use in the management of acute decompensated heart failure.左西孟旦：急性失代偿性心力衰竭治疗应用综述
Drugs. 2003;63(23):2651-71. doi: 10.2165/00003495-200363230-00009.
5
Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine.正常和患病人类心脏心室肌原纤维中镁 - 三磷酸腺苷酶（Mg - ATPase）和钙激活的肌球蛋白三磷酸腺苷酶（Ca + activated myosin AtPase）活性——钙敏化剂MCI - 154、DPI 201 - 106和咖啡因的作用
Mol Cell Biochem. 2003 Mar;245(1-2):77-89. doi: 10.1023/a:1022813726734.
6
Improved ventricular function by enhancing the Ca++ sensitivity in normal and stunned myocardium of isolated rabbit hearts.通过增强离体兔心脏正常和顿抑心肌中的钙离子敏感性来改善心室功能。
Basic Res Cardiol. 1994 Nov-Dec;89(6):549-62. doi: 10.1007/BF00794955.
7
Mechanisms of acute ischemic contractile failure of the heart. Role of intracellular calcium.心脏急性缺血性收缩功能衰竭的机制。细胞内钙的作用。
J Clin Invest. 1991 Aug;88(2):361-7. doi: 10.1172/JCI115311.
8
Calcium-sensitizing inotropic agents in the treatment of heart failure: a critical view.
Cardiovasc Drugs Ther. 1991 Dec;5(6):961-5. doi: 10.1007/BF00143520.
本文引用的文献
1
Activity of phosphorylase in total global ischaemia in the rat heart. A phosphorus-31 nuclear-magnetic-resonance study.大鼠心脏全脑缺血时磷酸化酶的活性。一项磷-31核磁共振研究。
Biochem J. 1981 Apr 15;196(1):171-8. doi: 10.1042/bj1960171.
2
Calcium transients in mammalian ventricular muscle.哺乳动物心室肌中的钙瞬变。
Eur Heart J. 1980;Suppl A:5-15. doi: 10.1093/eurheartj/1.suppl_1.5.
3
Oscillations of intracellular Ca2+ in mammalian cardiac muscle.哺乳动物心肌细胞内钙离子的振荡
Nature. 1983;304(5928):735-8. doi: 10.1038/304735a0.
4
Intracellular calcium concentration during hypoxia and metabolic inhibition in mammalian ventricular muscle.哺乳动物心室肌在缺氧和代谢抑制期间的细胞内钙浓度
J Physiol. 1983 Jun;339:107-22. doi: 10.1113/jphysiol.1983.sp014706.
5
Effects of caffeine on Ca-activated force production in skinned cardiac and skeletal muscle fibres of the rat.咖啡因对大鼠去表皮心肌和骨骼肌纤维中钙激活的力产生的影响。
Pflugers Arch. 1983 Aug;398(3):210-6. doi: 10.1007/BF00657153.
6
Cellular calcium fluctuations in mammalian heart: direct evidence from noise analysis of aequorin signals in Purkinje fibers.哺乳动物心脏中的细胞钙波动：来自浦肯野纤维中水母发光蛋白信号噪声分析的直接证据。
Proc Natl Acad Sci U S A. 1983 Dec;80(23):7367-71. doi: 10.1073/pnas.80.23.7367.
7
Digitalis glycosides: mechanisms and manifestations of toxicity. Part I.洋地黄苷：毒性机制与表现。第一部分。
Prog Cardiovasc Dis. 1984 Mar-Apr;26(5):413-58. doi: 10.1016/0033-0620(84)90012-4.
8
Positive inotropic agents.正性肌力药物
Annu Rev Pharmacol Toxicol. 1984;24:275-328. doi: 10.1146/annurev.pa.24.040184.001423.
9
Digitalis glycosides: mechanisms and manifestations of toxicity. Part II.洋地黄苷：毒性机制与表现。第二部分。
Prog Cardiovasc Dis. 1984 May-Jun;26(6):495-540. doi: 10.1016/0033-0620(84)90014-8.
10
Excitation-contraction coupling in cardiac Purkinje fibers. Effects of cardiotonic steroids on the intracellular [Ca2+] transient, membrane potential, and contraction.心脏浦肯野纤维中的兴奋-收缩偶联。强心甾类对细胞内[Ca2+]瞬变、膜电位和收缩的影响。
J Gen Physiol. 1984 Mar;83(3):395-415. doi: 10.1085/jgp.83.3.395.
Zotero 插件